The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 591,228 share decrease in total short interest for Infinity Pharmaceuticals Inc (INFI - Get Report), to 2,765,545, a decrease of 17.61% since 03/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for INFI at the 04/13/2017 settlement increased to 1,421,989, as compared to 676,954 at the 03/31/2017 report. That brought "days to cover" down to 1.94, a 60.78% decrease from the 4.96 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for INFI at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where INFI had been shorted as a hedge. The chart below shows the one year performance of INFI shares, versus its 200 day moving average. Looking at this chart, INFI's low point in its 52 week range is $0.84 per share, with $6.63 as the 52 week high point — that compares with a last trade of $2.09.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Replay: What to Watch in The Markets: AbbVie-Allergan, Micron, Buffett, and More
The ActionAlertsPLUS team breaks down what investors need to know on Tueday, including: AbbVie's acquistion of Allergan, Warren Buffett's Kraft comments and Micron earnings after the bell.
Amazon's 48-Hour Prime Day Is About Much More Than a Sales Windfall
Amazon's 48-hour Prime Day is one piece of a multifaceted strategy to lure more Prime members and encourage them to spend more money.
New Market, New Rules: Cramer's 'Mad Money' Recap (Tuesday 6/25/19)
Jim Cramer asks, can you recognize when you're getting needlessly greedy? Stick to the rules if you want to stay in the game for the long run.
FedEx Tops Fiscal Fourth-Quarter Earnings Estimates
Delivery giant says macroeconomic weakness and trade uncertainty will weigh on FedEx Express business in fiscal 2020.